Shigella Conjugate Vaccine from Japan
Shigella conjugate vaccine is a polysaccharide-protein conjugate vaccine targeting Shigella flexneri for diarrheal disease prophylaxis. It is an immunological product derived from microbial cultures and modified biotechnologically, classified under tariff item 3002.49.00 as 'Other' vaccines, toxins, or cultures of micro-organisms.
Duty Rate — Japan → Canada
0%
Import Tips
• Obtain a Health Canada approval for the vaccine before import, as it is a biological product
• Classify under 3002.49.00 and ensure the product is accompanied by a certificate of analysis
• Check for duty-free eligibility under the MFN tariff, but confirm with the CBSA for the latest rates